Inhalation Therapy Nebulizer Market To Achieve Stupendous Growth By 2026 – Zion Market Research

Zion Market Research has published a new report titled “Inhalation Therapy Nebulizer Market by Type (Pneumatic Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizer), by Applications (Asthma, COPD, Cystic Fibrosis, and Other), and by End-User (Hospitals and Clinics, Home Healthcare, and Other End-Users): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024”. According to the report, the global inhalation therapy nebulizer market was valued at approximately USD 794 million in 2017 and is expected to generate revenue of around USD 1,222 million by the end of 2024, growing at a CAGR of around 6.4% between 2018 and 2024.

Inhalation therapy aims to improve respiratory conditions in asthmatic and COPD patients to enable their normal breathing. Inhalation therapy uses a nebulizer device for administering the required drug. The nebulizer device converts drug solutions or suspensions in mist form (aerosol droplets). These aerosol droplets are easily absorbed by lungs. Many respiratory diseases and illnesses can be managed with a nebulizer owing to ease of use, as the drugs get administered directly to the target respiratory area. This helps to reduce the side effects, any other symptoms, and inflammation. Nebulizers can be used to treat the common cold, asthma, cystic fibrosis, COPD, and other respiratory diseases. There are mainly three types of nebulizers available in the market pneumatic nebulizers, ultrasonic nebulizers, and mesh nebulizers.

Government is taking initiatives to curb non-communicable diseases (NCD), like asthma and COPD, owing to the reduced quality of life in patients suffering from these diseases. Increasing cases of COPD, asthma, and other respiratory conditions drive the growth of inhalation therapy nebulizer market. Rising environmental pollution across the globe, growing geriatric population prone to various diseases, and increasing investments in product miniaturization for home healthcare use are other important drivers fuelling this market’s growth. Nevertheless, drug loss caused in the nebulizer device during conversion of the solution to mist leads to high drug requirement and is one of the major concerns that might hamper this market’s growth. Other diseases, such as diabetes, migraine, and cancer, can also be treated using inhalation therapy nebulizer, which might act as a growth opportunity for the inhalation therapy nebulizer market.

The global inhalation therapy nebulizer market segments are divided based on product type, applications, end-user, and region. On the basis of product type, this market is categorized into the ultrasonic nebulizer, mesh nebulizer, and pneumatic nebulizer, which are based on the mechanism of mist formation. Inhalation therapy nebulizers have applications in various respiratory conditions and based on applications, this market is segmented into asthma, COPD, cystic fibrosis, and other applications. Asthma segment is anticipated to hold the maximum share in this market, whereas COPD is expected to grow at the highest CAGR. End-users for inhalation therapy nebulizer market are hospitals and clinics, home healthcare, and other.

Get Free Sample of this Research Report – https://www.zionmarketresearch.com/market-analysis/inhalation-therapy-nebulizer-market

The global inhalation therapy nebulizer market is segmented into North America, Asia Pacific, Europe, the Middle East, and Africa, and Latin America based on regions. During the forecast period, North America is expected to hold the maximum share of the global inhalation therapy nebulizer market, owing to well-developed healthcare facilities and growing health awareness about respiratory diseases. The U.S. is expected to lead the market in the North American region. Europe will be second in dominating the market in terms of revenue share during the forecast period. The rapidly growing region is expected to be the Asia Pacific region during the forecast period. Moderate growth is expected in Latin America. The Middle East and Africa would show substantial growth during the forecast period.

Some key players of the inhalation therapy nebulizer market include Koninklijke Philips N.V., OMRON Corporation, DeVilbiss Healthcare, PARI, Air Liquide Medical Systems, A&D Company, Limited, GF Health Products, Inc., Vyaire Medical Inc., 3M, 3A Health Care S.R.L., Trudell Medical International, and Allied Healthcare Products, Inc., among others.

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.